ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,500Medicare Part D Prescriptions Filled, Including Refills

Rank: 115 out of 1802

$418K Total Retail Price of All Prescriptions

Rank: 165 out of 1802

351 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 351 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 351 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 7,151 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
FUROSEMIDE 440 420 1 5
WARFARIN SODIUM 326 290 2 7
OMEPRAZOLE 285 245 3 4
LISINOPRIL 273 245 4 3
HYDROCODONE-ACETAMINOPHEN 257 178 S3 5 10
SIMVASTATIN 244 209 6 1
LEVOTHYROXINE SODIUM 235 215 7 2
AMLODIPINE BESYLATE 205 198 8 6
MIRTAZAPINE 178 146 9 38
METOPROLOL TARTRATE 173 154 10 9
HYDROCHLOROTHIAZIDE 157 144 11 8
DONEPEZIL HCL 157 157 11 26
NAMENDA 145 145 13 34
GABAPENTIN 143 102 14 16
CITALOPRAM HBR 140 104 15 17
POTASSIUM CHLORIDE 137 133 16 15
FENTANYL 116 79 S2 17 43
PRAVASTATIN SODIUM 111 101 18 19
ATENOLOL 105 100 19 12
FLUTICASONE PROPIONATE 104 79 20 37
LOSARTAN POTASSIUM 93 85 21 18
METFORMIN HCL 92 82 22 11
METOPROLOL SUCCINATE 90 86 23 13
SERTRALINE HCL 88 73 24 20
CARVEDILOL 86 78 25 36
POLYETHYLENE GLYCOL 3350 82 70 26 29
MORPHINE SULFATE ER 81 41 S2 27 71
LANTUS SOLOSTAR 71 63 28 63
TRAMADOL HCL 67 53 29 22
PLAVIX 61 58 30 81
ALLOPURINOL 60 42 31 24
ENALAPRIL MALEATE 60 59 31 40
GLIPIZIDE 60 58 31 51
TRAZODONE HCL 58 40 34 39
KLOR-CON 10 58 58 34 117
TRIAMCINOLONE ACETONIDE 58 57 34 91
RANITIDINE HCL 55 33 37 30
DIGOXIN 53 40 38 45
RISPERIDONE 52 48 39 64
TRIAMTERENE-HCTZ 51 51 40 49
PRAMIPEXOLE DIHYDROCHLORIDE 50 50 41 172
ADVAIR DISKUS 50 45 41 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 19, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.